Toronto, Ontario–(Newsfile Corp. – October 19, 2021) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the preliminary data revealing a potential new functional property and health benefit of AME-1.

Source

Previous articleField Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton
Next articleCybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies